Haemonetics Corporation (HAE) Financial Statements (2026 and earlier)

Company Profile

Business Address 125 SUMMER STREET
BOSTON, MA 02110
State of Incorp. MA
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2025
MRQ
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments306,763178,800284,466259,496192,305137,311
Cash and cash equivalent306,763178,800284,466259,496192,305137,311
Receivables202,657206,562179,142159,376127,555165,207
Inventory, net of allowances, customer advances and progress billings365,141317,202259,379293,027322,614270,276
Inventory365,141317,202259,379293,027322,614270,276
Other undisclosed current assets60,41466,33946,73544,13251,07230,845
Total current assets:934,975768,903769,722756,031693,546603,639
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization284,052311,362310,885258,482217,559253,399
Intangible asset, including goodwill, after accumulated amortization1,060,012971,199742,002777,548831,927343,758
Goodwill604,269565,082466,231467,287466,444210,652
Intangible asset, excluding goodwill, after accumulated amortization455,743406,117275,771310,261365,483133,106
Deferred income tax assets7,8037,7395,2414,4686,0093,930
Other noncurrent assets164,106136,388106,97563,20570,88262,384
Total noncurrent assets:1,515,9731,426,6881,165,1031,103,7031,126,377663,471
TOTAL ASSETS:2,450,9482,195,5911,934,8251,859,7341,819,9231,267,110
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities126,422154,066128,404106,91197,893100,201
Employee-related liabilities64,47548,54047,60049,471
Accounts payable66,99973,35863,92958,37150,29350,730
Accrued liabilities59,42380,708    
Debt303,55810,22911,784214,14817,01676,980
Other liabilities148,133136,088111,628121,207138,58697,641
Total current liabilities:578,113300,383251,816442,266253,495274,822
Noncurrent Liabilities
Long-term debt and lease obligation921,230797,564754,102559,441690,592305,513
Long-term debt, excluding current maturities921,230797,564754,102559,441690,592305,513
Liabilities, other than long-term debt130,769137,685110,910108,603144,16699,666
Deferred income tax liabilities62,57562,64436,19528,72743,82510,562
Other liabilities68,19475,04174,71579,876100,34189,104
Total noncurrent liabilities:1,051,999935,249865,012668,044834,758405,179
Total liabilities:1,630,1121,235,6321,116,8281,110,3101,088,253680,001
Equity
Equity, attributable to parent820,836959,959817,997749,424731,670587,109
Common stock482508504511509503
Additional paid in capital523,264634,627594,706572,476602,727553,229
Accumulated other comprehensive loss(55,084)(35,632)(30,381)(25,954)(29,547)(45,135)
Retained earnings352,174360,456253,168202,391157,98178,512
Total equity:820,836959,959817,997749,424731,670587,109
TOTAL LIABILITIES AND EQUITY:2,450,9482,195,5911,934,8251,859,7341,819,9231,267,110

Income Statement (P&L) ($ in thousands)

12/31/2025
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Revenues1,360,8241,309,0551,168,660993,196870,463988,479
Cost of revenue
(Cost of Product and Service Sold)
(611,866)(617,507)(553,563)(487,694)(472,625)(503,966)
Gross profit:748,958691,548615,097505,502397,838484,513
Operating expenses(527,141)(526,665)(459,064)(424,752)(308,091)(381,162)
Operating income:221,817164,883156,03380,75089,747103,351
Nonoperating expense
(Other Nonoperating expense)
(9,746)(13,018)(14,630)(17,121)(16,834)(16,199)
Interest and debt expense 12,600(19,500)(13,000)(5,800)(9,400)(13,500)
Other undisclosed income from continuing operations before equity method investments, income taxes    9,40013,500
Income from continuing operations before equity method investments, income taxes:224,671132,365128,40357,82972,91387,152
Other undisclosed income (loss) from continuing operations before income taxes(12,600)19,50013,0005,800  
Income from continuing operations before income taxes:212,071151,865141,40363,62972,91387,152
Income tax expense (benefit)(44,392)(34,307)(26,002)(20,254)6,556(10,626)
Income from continuing operations:167,679117,558115,40143,37579,46976,526
Income before gain (loss) on sale of properties:43,37579,46976,526
Net income available to common stockholders, diluted:167,679117,558115,40143,37579,46976,526

Comprehensive Income ($ in thousands)

12/31/2025
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Net income:167,679117,558115,40143,37579,46976,526
Other comprehensive income (loss)(19,452)(5,251)(4,427)3,59315,588(14,755)
Comprehensive income, net of tax, attributable to parent:148,227112,307110,97446,96895,05761,771

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: